Copertina

Invited letter MUC4 mutations as an amplifier of complement‐mediated thrombosis in paroxysmal nocturnal haemoglobinuria

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Eng Soo Yap, Edwin Wei Sheng Thong, Cheryl Xiu Qi Lim
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Clinical and Translational Discovery
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

MUC4 mutations promote a thrombotic phenotype in patients with paroxysmal nocturnal haemoglobinuria by increasing the deposition of terminal complement
di: Yingying Chen, et al.
Pubblicazione: (2026)

Anti‐PF4 antibody inhibit proliferation of lung cancer cells without TP53 mutation by inducing apoptosis and cell cycle arrest
di: Mengjia Qian, et al.
Pubblicazione: (2025)

A new member at the table: Granzyme K as a lymphocyte‐born complement initiator
di: Manoj Kumar Pandey
Pubblicazione: (2025)

Targeting mutated KRAS in the first‐line therapy
di: Hideaki Ijichi
Pubblicazione: (2024)

Precision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer
di: Yiyi Yu, et al.
Pubblicazione: (2024)

GPR183 ‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer
di: Ling Ye, et al.
Pubblicazione: (2026)

Drug Sensitivity patterns across FAB subtypes and molecular mutations in AML: A comprehensive analysis for precision medicine
di: Mobina Shrestha, et al.
Pubblicazione: (2025)

Beyond the paradox: Cardiac‐specific miR‐106a delivery as a translational turning point for heart failure?
di: Wei‐Wen Lim
Pubblicazione: (2025)

Sex differences in structural cell‐mediated immune regulation: Implications for precision respiratory medicine
di: Quocdai Vu, et al.
Pubblicazione: (2026)

Otubain 2 promotes muramyl dipeptide‐mediated anti‐colitogenic effects due to de‐ubiquitination of receptor interaction protein 2
di: Jochen Mattner
Pubblicazione: (2024)

Established a therapeutic response prediction model in metastatic gastric cancer by liquid biopsy
di: Sheng Liu, et al.
Pubblicazione: (2024)

CEACAM6: A potential prognostic biomarker and therapeutic target in cholangiocarcinoma
di: Jia‐Qi Guo, et al.
Pubblicazione: (2026)

CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin
di: Shi‐Jia Dai, et al.
Pubblicazione: (2026)

Sex differences in genomics, immune microenvironment and immunotherapy response in adult grade 4 gliomas
di: Feng Tang, et al.
Pubblicazione: (2026)

Evaluating the potential risks of employing large language models in peer review
di: Lingxuan Zhu, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)

Milk exosomes: Harnessing nature's duality for cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

A comprehensive atlas of pediatric immune checkpoint inhibitors‐related adverse events: From real‐world pharmacovigilance data to mechanistic insights
di: Anqi Lin, et al.
Pubblicazione: (2025)

High‐fat diet effects on brain mitochondrial complex I activity and protein lipoxidation: implications for translational medicine
di: Vetriselvan Subramaniyan, et al.
Pubblicazione: (2024)

INTEGRAL‐ILCCO cohort data analysis revealed the association of clonal haematopoiesis with an increased risk of lung cancer
di: Chao Cheng, et al.
Pubblicazione: (2024)

Deep learning for predicting synergistic drug combinations: State‐of‐the‐arts and future directions
di: Yu Wang, et al.
Pubblicazione: (2024)

A new metabolic signature to predict melanoma recurrence
di: Ngan K. Vu, et al.
Pubblicazione: (2024)

Unveiling a novel cellular stress response mechanism to photodamage
di: Naibedya Dutta, et al.
Pubblicazione: (2024)

Research progress on fusion genes in tumours
di: Yinyi Chang, et al.
Pubblicazione: (2024)

Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatment
di: Xiaolu Zhang, et al.
Pubblicazione: (2024)

Roads diverged in a wood: Proteins and RNAs encoded by cytochrome b (CYTB) gene in health and disease
di: Cijie Du, et al.
Pubblicazione: (2025)

Astrocytes as central integrators of neural circuit function: Mechanisms and dysregulation in neuropsychiatric disorders
di: Xinyu Liu, et al.
Pubblicazione: (2026)

Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer
di: Wei‐Ling Tu, et al.
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2025)

From channel‐spatial attention to state space models: A review of evolving mechanisms in tumour segmentation
di: Yanfei Sun, et al.
Pubblicazione: (2026)

Single‐cell RNA sequencing reveals telocytes subsets of human lung
di: Lihua Dai, et al.
Pubblicazione: (2024)

Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
di: Swastika Maitra, et al.
Pubblicazione: (2024)

Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

Potential diagnostic and distinguishing roles of microneedle‐based biosensors in bacterial and aseptic meningitis
di: Hamid Sadeghi, et al.
Pubblicazione: (2024)

Gastric cancer detection based on cell‐free DNA in blood: A systematic review and meta‐analysis
di: Mona Wang, et al.
Pubblicazione: (2024)

Effects of microRNA on the growth and targeted therapy response on lung cancer
di: Mengchen Zhu, et al.
Pubblicazione: (2024)

Clinical signature of exosomal tetraspanin proteins in cancer
di: Asmit Das, et al.
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2026)

Gut microbiota and central nervous system's direct bidirectional regulation: The mechanisms of the gut–brain axis in irritable bowel syndrome
di: Jinxia Zhai, et al.
Pubblicazione: (2026)

Heterogeneous nuclear ribonucleoprotein A2/B1, a key regulator of myocardial fibrosis
di: Ji‐Hoon Jeong, et al.
Pubblicazione: (2024)